Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC

Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea
Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBC ( Prof Sung-Bae Kim - Asan Medical Center, Seoul, South Korea )
31 May 2025

Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma

Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands
Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma ( Prof Martin van den Bent - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
31 May 2025

Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer

Dr Jean Abraham - University of Cambridge, Cambridge, UK
Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )
22 May 2025

Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

Dr Ricky Frazer and Dr Sree Subramanian
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective ( Dr Ricky Frazer and Dr Sree Subramanian )
19 May 2025

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA
WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )
7 May 2025

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA
Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )
7 May 2025

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom
ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )
25 Apr 2025

Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC

Prof Suresh Senan - University Medical Centers, Amsterdam, The Netherlands
Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC ( Prof Suresh Senan - University Medical Centers, Amsterdam, The Netherlands )
7 Apr 2025

Urine test could reduce post-op scans for kidney cancer by half

Dr Saeed Dabestani - Lund university, Lund, Sweden
Urine test could reduce post-op scans for kidney cancer by half ( Dr Saeed Dabestani - Lund university, Lund, Sweden )
27 Mar 2025

Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC

Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )
27 Mar 2025

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )
11 Mar 2025

Talazoparib and enzalutamide combination therapy shows significant benefit in treating mCRPC

Prof Neeraj Agarwal - University of Utah, Salt Lake City, USA
Talazoparib and enzalutamide combination therapy shows significant benefit in treating mCRPC ( Prof Neeraj Agarwal - University of Utah, Salt Lake City, USA )
5 Mar 2025